Forty Seven Inc. to Report Second Quarter 2019 Financial Results on Tuesday, August 13, 2019

    NEXT STORY
    Akcea and Ionis Report Top-line Results from the BROADEN Study with WAYLIVRA® (volanesorsen) in Patients with Familial Partial Lipodystrophy
    PREV STORY
    Idera to Release 2019 Second Quarter Results on August 8, 2019
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Global molecular diagnostics (MDx) point of care market to expand at 13% CAGR during 2020-2025

    author_avatar
    NASDAQ Market News

    Roche presents positive phase III study results for one-dose Xofluza in children with flu

    author_avatar
    NASDAQ Market News

    National Lipid Association’s New Position Statement on Use of Icosapent Ethyl in High and Very-High-Risk Patients Recognizes Importance of Addressing Residual Cardiovascular Risk in Patients on Statins

    author_avatar
    NASDAQ Market News